Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas

被引:57
作者
Haralambieva, E
Pulford, KAF
Lamant, L
Pileri, S
Roncador, G
Gatter, KC
Delsol, G
Mason, DY
机构
[1] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Leukaemia Res Fund Immunodiagnost Unit, Oxford OX3 9DU, England
[2] CHU Purpan, Dept Pathol, Toulouse, France
[3] CHU Purpan, CIGH, CNRS, Toulouse, France
[4] St Orsola Polyclin, Sect Haemolymphopathol Histol, Bologna, Italy
关键词
anaplastic large-cell lymphoma; B-cell markers; ALK protein; (2; 5) translocation; diffuse large B-cell lymphoma;
D O I
10.1046/j.1365-2141.2000.02045.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is controversy in the literature as to whether anaplastic large-cell lymphoma of B-cell phenotype is related to the t(2;5)-positive T- or 'null' cell lymphoma of the same morphology. We report a study of 24 lymphomas with morphological features of anaplastic large-cell lymphoma which expressed one or more B-cell markers and lacked T-lineage markers. Clinical features were more in keeping with large B-cell lymphoma than with classical t(2:5)-positive anaplastic large-cell lymphoma, and immunostaining for anaplastic lymphoma kinase (ALK) protein provided no evidence for the (2;5) translocation (or one of its variants). The staining patterns for CD20 and CD79 were typical of diffuse large B-cell lymphoma, CD30 expression was variable, and most cases (15/22) lacked epithelial membrane antigen (EMA). These findings support the view that 'B-cell anaplastic large-cell lymphoma' is unrelated to t(2:5)-positive (ALK-positive) lymphoma, and that it represents a morphological pattern occasionally encountered among diffuse large B-cell lymphomas. By the same reasoning, most tumours diagnosed as ALK-negative anaplastic large-cell lymphoma of T-cell or null phenotype' probably belong to the spectrum of peripheral T-cell lymphomas.
引用
收藏
页码:584 / 591
页数:8
相关论文
共 43 条
[11]   A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation [J].
Delsol, G ;
Lamant, L ;
Mariame, B ;
Pulford, K ;
Dastugue, N ;
Brousset, P ;
RigalHuguet, F ;
AlSaati, T ;
Cerretti, DP ;
Morris, SW ;
Mason, DY .
BLOOD, 1997, 89 (05) :1483-1490
[12]   MOLECULAR-DETECTION OF THE (2-5) TRANSLOCATION OF NON-HODGKINS-LYMPHOMA BY REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION [J].
DOWNING, JR ;
SHURTLEFF, SA ;
ZIELENSKA, M ;
CURCIOBRINT, AM ;
BEHM, FG ;
HEAD, DR ;
SANDLUND, JT ;
WEISENBURGER, DD ;
KOSSAKOWSKA, AE ;
THORNER, P ;
LORENZANA, A ;
LADANYI, M ;
MORRIS, SW .
BLOOD, 1995, 85 (12) :3416-3422
[13]  
Engelhard M, 1997, BLOOD, V89, P2291
[14]   ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum [J].
Falini, B ;
Bigerna, B ;
Fizzotti, M ;
Pulford, K ;
Pileri, SA ;
Delsol, G ;
Carbone, A ;
Paulli, M ;
Magrini, U ;
Menestrina, F ;
Giardini, R ;
Pilotti, S ;
Mezzelani, A ;
Ugolini, B ;
Billi, M ;
Pucciarini, A ;
Pacini, R ;
Pelicci, PG ;
Flenghi, L .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :875-886
[15]  
FALINI B, 1995, BLOOD, V85, P1
[16]   Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules [J].
Foss, HD ;
Anagnostopoulos, I ;
Araujo, I ;
Assaf, C ;
Demel, G ;
Kummer, JA ;
Hummel, M ;
Stein, H .
BLOOD, 1996, 88 (10) :4005-4011
[17]   Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma [J].
Gascoyne, RD ;
Aoun, P ;
Wu, D ;
Chhanabhai, M ;
Skinnider, BF ;
Greiner, TC ;
Morris, SW ;
Connors, JM ;
Vose, JM ;
Viswanatha, DS ;
Coldman, A ;
Weisenburger, DD .
BLOOD, 1999, 93 (11) :3913-3921
[18]  
HARRIS NL, 1994, BLOOD, V84, P1361
[19]   ALK GENE-PRODUCTS IN ANAPLASTIC LARGE-CELL LYMPHOMAS AND HODGKINS-DISEASE [J].
HERBST, H ;
ANAGNOSTOPOULOS, J ;
HEINZE, B ;
DURKOP, H ;
HUMMEL, M ;
STEIN, H .
BLOOD, 1995, 86 (05) :1694-1700
[20]   Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: Evidence for distinct cellular origin [J].
Krenacs, L ;
Wellmann, A ;
Sorbara, L ;
Himmelmann, AW ;
Bagdi, E ;
Jaffe, ES ;
Raffeld, M .
BLOOD, 1997, 89 (03) :980-989